Emvision Medical Devices Ltd. · ASX:EMV
Emvision Medical Devices — E&P Healthcare Conference 2022
25 slides from Emvision Medical Devices's conference presentation, Sep 6, 2022
Slide 1: E&P Healthcare Conference Presentation
6/09/22 EMvision Medical Devices Ltd ACN 620 388 230 Level 10, 12 Creek Street, Brisbane Qld 4000 02 8667 5337 contact@emvision.com.au For personal use only E&P HEALTHCARE CONFERENCE PRESENTATION EMVision Medical Devices Limited (ASX:EMV) (“EMVision” or the “Company”), a medical device company focus
Slide 2: About EMVision Medical Devices
About EMVision Medical Devices EMVision Medical Devices Limited is focused on the development and commercialisation of medical imaging technology. The Company is developing and seeking to commercialise a potentially cost effective, portable, medical imaging device using electromagnetic microwave ima
Slide 3: Electromagnetic imaging to revolutionise stroke diagnosis and monitoring
www.emvision.com.au E&P HEALTHCARE For personal use only CONFERENCE Electromagnetic imaging to revolutionise stroke diagnosis and monitoring SEPTEMBER 2022 ASX:EMV
Slide 4: Disclaimer
DISCLAIMER For personal use only This presentation has been prepared by EMVision Medical Devices Limited (“EMVision” or “the Company”). This presentation is not a financial product or investment advice or recommendation, offer or invitation by any person or to any person to sell or purchase securiti
Slide 5: Overview
OVERVIEW For personal use only EMVision is an innovative medical device company developing world first electromagnetic portable brain scanner products to address significant unmet needs Founded in 2017 Experienced team “Zero to one” (including key ex- technology Nanosonics leaders) Best-in-breed Sig
Slide 6: Capital Structure
CAPITAL STRUCTURE • Secured >$17m in non-dilutive funding since inception For personal use only • $6.8m cash balance at 30 June 2022, modest cash Headquarters: burn 4.01, 65 Epping Road, Macquarie Park Sydney, Australia • Further $11.2m ongoing non-dilutive grant funding sources ASX TICKER: EMV • Mu
Slide 7: EMVision is creating world first portable brain scanners
EMVISION IS For personal use only CREATING WORLD FIRST PORTABLE Neuroimaging as is BRAIN SCANNERS accessible today. EMV 1st Gen, Neuroimaging anywhere. www.emvision.com.au 5
Slide 8: Bringing imaging to where stroke occurs will save lives
BRINGING IMAGING TO TRADITIONAL IMAGING TOOLS For personal use only WHERE STROKE OCCURS • Mainstay imaging techniques, CT and MRI, produce excellent images but are for the most part large, stationary and WILL SAVE LIVES complex machines that require specialist operators, limiting their point-of-care
Slide 9: Filling a gap where no alternative imaging solutions readily accessible
FILLING A GAP WHERE NO ALTERNATIVE IMAGING SOLUTIONS READILY ACCESSIBLE UNMET NEED FOR PRE-HOSPITAL AND BEDSIDE IMAGING ACROSS THE ENTIRE PATIENT JOURNEY For personal use only A typical patient journey & timeline 15 mins to 2.5hrs <2.5 hours <3 hours <24 hours <24 hours 3 weeks <3 weeks 3 years + Pr
Slide 10: 1st Gen: Detect clinically significant changes at the bedside
1ST GEN DETECT CLINICALLY SIGNIFICANT For personal use only CHANGES, AT THE BEDSIDE, WHEN TIME MATTERS. • A portable, cost-effective, non-ionizing and safe brain scanner • Capable of rapidly producing quality images of biological tissue to provide game-changing insights for clinicians by the bedside
Slide 11: Positive market feedback – encouraging health economics
POSITIVE MARKET FEEDBACK – ENCOURAGING HEALTH ECONOMIC 1ST GEN PORTABLE BRAIN ASSESSMENT For personal use only SCANNER Estimated Gen 1 potential financial benefits to a public hospital in Australia¹ • 20 US based stroke specialists, with involvement in purchasing processes, surveyed by IDR Medical.
Slide 12: 2nd Gen: Ultra light weight device for ambulances
2ND GEN ULTRA LIGHT WEIGHT DEVICE FOR For personal use only STANDARD ROAD AND AIR AMBULANCES • Lightweight scalable imaging solution with telemedicine capabilities, tablet operated. • Designed to assist with remote diagnosis • Portable, in ambulances and carried into the home of a patient – helps wi
Slide 13: More lives could be saved with scalable 2nd Gen solution
MORE LIVES COULD BE SAVED • Mobile Stroke Units (MSU) essentially bring the stroke unit to the patient, providing faster diagnosis and treatment, improving disability For personal use only WITH OUR SCALABLE AND outcomes • However, the model is resource intensive (including radiographer) and LIGHTWEI
Slide 14: Unique technology platform
UNIQUE TECHNOLOGY Low energy PLATFORM electromagnetic pulses For personal use only are used to provide a • Safe, portable, fast and accessible imaging modality mobile, and rapid neuroimaging modality • IP portfolio spans software, hardware and multiple indications for pre-hospital and • Successful p
Slide 15: Clinical trial roadmap – Gen 1
CLINICAL TRIAL ROADMAP – GEN 1 For personal use only LOCATION PARTICIPANTS REPORTING DURATION Site 1 - Liverpool Hospital Presenting to emergency The Company expects to provide Anticipated to be 12+ months Site 2 - Royal Melbourne Hospital department with suspected stroke updates to the market as it
Slide 16: Attractive revenue models
MONTHLY SUBSCRIPTION MODEL ATTRACTIVE REVENUE (GEN 1) For personal use only MODELS • • Target ~$8,000 USD / month (subject to term) Delivery of the unit and training • Consumables (subject to quota) • Traditional Capex or innovative Opex • Software upgrades pricing model offerings to provide buyer f
Slide 17: Addressable market
ADDRESSABLE MARKET TOTAL INSTALLED BASE OPPORTUNITY For personal use only 1st GEN ADDRESSABLE MARKET US. GER, FR, UK AU ROW TOTAL ADDRESSABLE MARKET ~$15Bn – 1st GEN 10,200 5,960 545 86,000 FIRST TARGETS 1,600 PSC / CSC 642 PSC / CSC 93 PSC / CSC PSC = Primary Stroke Centre CSC = Comprehensive Strok
Slide 18: Significant experience developing and commercialising medical devices
SIGNIFICANT EXPERIENCE DEVELOPING AND COMMERICALISING MEDICAL DEVICES For personal use only Team of 30 across Sydney and Brisbane, in R&D and product development Dr. Ron Weinberger Scott Kirkland Professor Stuart Crozier Robert Tiller CEO and Managing Director Co-founder and Executive Director Chief
Slide 19: Partners & collaborators
PARTNERS & COLLABORATORS For personal use only TRACK RECORD OF SECURING AND ONGOING ACCESS TO NON-DILUTIVE FUNDING PROVIDES GOOD FLEXIBILITY Clinical Research Partnership Access to neurology, radiology and critical care expertise, access to simulation rooms and hospital infrastructure, advancement o
Slide 20: Strong support from the clinical community
STRONG SUPPORT FROM THE CLINICAL COMMUNITY For personal use only “The concept of bringing imaging “It cannot be underestimated “Equitable healthcare for remote to the patient will dramatically how important this cutting- Australians needs to overcome reduce times to administer life edge technology c
Slide 21: Summary and outlook
05 www.manjur.com SUMMARY AND OUTLOOK For personal use only • Team of medtech experts that have successfully done this before • Strong support from the leading minds in stroke care • Increasing demand globally for point-of-care imaging • Multi-billion-dollar market opportunity in stroke care • Techn
Slide 22: Thank you
For personal use only THANK YOU EM VISION WEBSITE EMAIL HEADQUARTERS ASX:EMV www.emvision.com.au info@emvision.com.au 4.01, 65 Epping Road, Macquarie Park Sydney, Australia
Slide 23: Appendix
For personal use only APPENDIX
Slide 24: Experienced Board
EXPERIENCED BOARD For personal use only John Keep Dr. Ron Weinberger Scott Kirkland Non-Executive Chairman CEO and Managing Director Executive Director As former CEO of Queensland Diagnostic Imaging, John grew Former Executive Director and CEO of Nanosonics' (ASX:NAN). Co-founder of EMVision Medical
Slide 25: Our History
OUR HISTORY For personal use only Breakthrough technology $5m MMI developments – Grant Win to EMVision wins Dielectric Maps and establish commonwealth CRC-P Grant Demonstrates stroke Pulsatility commercial with collaborators GE Invited to join subtype classification manufacturing Healthcare, UQ and
EMVision Medical Devices — E&P Healthcare Conference 2022 on 6ix